Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekena, K.
Right arrow Articles by Katzenellenbogen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekena, K.
Right arrow Articles by Katzenellenbogen, B. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 33, Issue of August 16, 1996 pp. 20053-20059
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Identification of Amino Acids in the Hormone Binding Domain of the Human Estrogen Receptor Important in Estrogen Binding

(Received for publication, April 1, 1996, and in revised form, May 1, 1996)

Kirk Ekena Dagger , Karen E. Weis Dagger , John A. Katzenellenbogen § and Benita S. Katzenellenbogen Dagger

From the Dagger  Department of Molecular and Integrative Physiology and § Department of Chemistry, University of Illinois, Urbana, Illinois 61801

The initial step in the regulation of the transcriptional activity of the estrogen receptor (ER) is the binding of hormone. Previous studies have suggested that the region between amino acids 515 and 535 near the C terminus of the human ER is likely to be important in ligand binding. In order to explicitly define which amino acids in this region are critical for ligand recognition and binding, we have utilized alanine-scanning mutagenesis over the complete 515-535 region. The ability of these 21 mutants to activate transcription in response to the natural estrogen, 17beta -estradiol (E2), was evaluated in cell co-transfection assays with estrogen-responsive reporter genes. In addition, their ability to bind E2 was also tested. Mutations at four sites in the 521-528 region had the greatest effects on E2-induced transcription, with L525A reducing responsiveness 250-fold, G521A and H524A 35-fold, and M528A 11-fold. Mutations at other sites had either no effect or a 4-fold or lesser reduction in sensitivity to E2 (M517A, Y526A, N532A, and P535A). Three of the mutants most affected in their transcriptional response, G521A, H524A, and M528A, showed a coordinate reduction in E2 binding affinity. E2 binding by the most affected mutant, L525A, could not be detected. Thus, the altered transcriptional response of these ER mutants appears to derive solely from an alteration in their affinity for the ligand E2. The four sites most affected by alanine substitution, 521, 524, 525, and 528, follow an alpha -helical periodicity, such that they would be positioned on one face of an alpha -helix. Furthermore, they correspond precisely to residues in an alpha -helix shown to be in contact with ligand in the recently described x-ray crystal structures of two other members of the nuclear hormone receptor superfamily, namely the retinoic acid receptor- and thyroid hormone receptor-ligand complexes. Our findings, which broaden observations to the steroid receptor family within the superfamily of nuclear receptors, suggest that this region of the estrogen receptor is in contact with its cognate ligand in a similar fashion.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
M. T. Sonoda, L. Martinez, P. Webb, M. S. Skaf, and I. Polikarpov
Ligand Dissociation from Estrogen Receptor Is Mediated by Receptor Dimerization: Evidence from Molecular Dynamics Simulations
Mol. Endocrinol., July 1, 2008; 22(7): 1565 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. Paulmurugan, A. Tamrazi, J. A. Katzenellenbogen, B. S. Katzenellenbogen, and S. S. Gambhir
A Human Estrogen Receptor (ER){alpha} Mutation with Differential Responsiveness to Nonsteroidal Ligands: Novel Approaches for Studying Mechanism of ER Action
Mol. Endocrinol., July 1, 2008; 22(7): 1552 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. I. Aguirre, L. I. Plotkin, A. R. Gortazar, M. M. Millan, C. A. O'Brien, S. C. Manolagas, and T. Bellido
A Novel Ligand-independent Function of the Estrogen Receptor Is Essential for Osteocyte and Osteoblast Mechanotransduction
J. Biol. Chem., August 31, 2007; 282(35): 25501 - 25508.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M Maggiolini, A G Recchia, D Bonofiglio, S Catalano, A Vivacqua, A Carpino, V Rago, R Rossi, and S Ando
The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor {alpha} in human breast cancer cells
J. Mol. Endocrinol., October 1, 2005; 35(2): 269 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A.L. Filby and C.R. Tyler
Molecular Characterization of Estrogen Receptors 1, 2a, and 2b and Their Tissue and Ontogenic Expression Profiles in Fathead Minnow (Pimephales promelas)
Biol Reprod, October 1, 2005; 73(4): 648 - 662.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. B. Hawkins and P. Thomas
The Unusual Binding Properties of the Third Distinct Teleost Estrogen Receptor Subtype ER{beta}a Are Accompanied by Highly Conserved Amino Acid Changes in the Ligand Binding Domain
Endocrinology, June 1, 2004; 145(6): 2968 - 2977.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. Furuta, A. K. Suzuki, S. Taneda, K. Kamata, H. Hayashi, Y. Mori, C. Li, G. Watanabe, and K. Taya
Estrogenic Activities of Nitrophenols in Diesel Exhaust Particles
Biol Reprod, May 1, 2004; 70(5): 1527 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Frasor, F. Stossi, J. M. Danes, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen
Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells
Cancer Res., February 15, 2004; 64(4): 1522 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Sun, J. Baudry, J. A. Katzenellenbogen, and B. S. Katzenellenbogen
Molecular Basis for the Subtype Discrimination of the Estrogen Receptor-{beta}-Selective Ligand, Diarylpropionitrile
Mol. Endocrinol., February 1, 2003; 17(2): 247 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. C. Nye, R. R. Rajendran, D. L. Stenoien, M. A. Mancini, B. S. Katzenellenbogen, and A. S. Belmont
Alteration of Large-Scale Chromatin Structure by Estrogen Receptor
Mol. Cell. Biol., May 15, 2002; 22(10): 3437 - 3449.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Maggiolini, D. Bonofiglio, S. Marsico, M. L. Panno, B. Cenni, D. Picard, and S. Ando
Estrogen Receptor alpha Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Two Major Phytoestrogens on Human Breast Cancer Cells
Mol. Pharmacol., September 1, 2001; 60(3): 595 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. B. Hawkins, J. W. Thornton, D. Crews, J. K. Skipper, A. Dotte, and P. Thomas
Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts
PNAS, September 26, 2000; 97(20): 10751 - 10756.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Thénot, S. Bonnet, A. Boulahtouf, E. Margeat, C. A. Royer, J.-L. Borgna, and V. Cavaillès
Effect of Ligand and DNA Binding on the Interaction between Human Transcription Intermediary Factor 1{alpha} and Estrogen Receptors
Mol. Endocrinol., December 1, 1999; 13(12): 2137 - 2150.
[Abstract] [Full Text]

Home page
 Cardiovasc ResHome page
E. Tan, M. V Gurjar, R. V Sharma, and R. C Bhalla
Estrogen receptor-{alpha} gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration
Cardiovasc Res, August 15, 1999; 43(3): 788 - 797.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Sasano, T. Suzuki, Y. Matsuzaki, T. Fukaya, M. Endoh, H. Nagura, and M. Kimura
Messenger Ribonucleic Acid in Situ Hybridization Analysis of Estrogen Receptors {alpha} and {beta} in Human Breast Carcinoma
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 781 - 785.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
C. Logie, M. Nichols, K. Myles, J. W. Funder, and A. F. Stewart
Positive and Negative Discrimination of Estrogen Receptor Agonists and Antagonists Using Site-Specific DNA Recombinase Fusion Proteins
Mol. Endocrinol., August 1, 1998; 12(8): 1120 - 1132.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
K. Ekena, J. A. Katzenellenbogen, and B. S. Katzenellenbogen
Determinants of Ligand Specificity of Estrogen Receptor-alpha : Estrogen versus Androgen Discrimination
J. Biol. Chem., January 9, 1998; 273(2): 693 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Pettersson, K. Grandien, G. G. J. M. Kuiper, and J.-A. Gustafsson
Mouse Estrogen Receptor {beta} Forms Estrogen Response Element-Binding Heterodimers with Estrogen Receptor {alpha}
Mol. Endocrinol., September 1, 1997; 11(10): 1486 - 1496.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
W. P. Bocchinfuso and K. S. Korach
Estrogen Receptor Residues Required for Stereospecific Ligand Recognition and Activation
Mol. Endocrinol., May 1, 1997; 11(5): 587 - 594.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
B. S. Katzenellenbogen and K. S. Korach
Editorial: A New Actor in the Estrogen Receptor Drama--Enter ER-{beta}
Endocrinology, March 1, 1997; 138(3): 861 - 862.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Ekena, K. E. Weis, J. A. Katzenellenbogen, and B. S. Katzenellenbogen
Different Residues of the Human Estrogen Receptor Are Involved in the Recognition of Structurally Diverse Estrogens and Antiestrogens
J. Biol. Chem., February 21, 1997; 272(8): 5069 - 5075.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. F. Arnold, M. Melamed, D. P. Vorojeikina, A. C. Notides, and S. Sasson
Estradiol-Binding Mechanism and Binding Capacity of the Human Estrogen Receptor Is Regulated by Tyrosine Phosphorylation
Mol. Endocrinol., January 1, 1997; 11(1): 48 - 53.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. T. Preisler-Mashek, N. Solodin, B. L. Stark, M. K. Tyriver, and E. T. Alarid
Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E891 - E898.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement